Each year, hundreds of thousands of horseshoe crabs are netted and drained of their milky-blue blood. It’s used for medical safety tests that detect bacterial contamination in drugs and implants. According to a recent Reuters article, activists from The National Audubon Society, Defenders of Wildlife, and other groups are pressuring the pharmaceutical industry to switch to a synthetic version of the blood, known as recombinant Factor C (rFC).
Quick Hits: Wildlife Activists Target Big Pharma for Using Too Much Crab Blood
Wildlife advocates want drugmakers to cease use of horseshoe crab blood in favor of a synthetic alternative.
Jun 24, 2020
LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
REGISTER ASAP FOR $30!